Americans exposed to Ebola to get experimental antibody therapy amid Kenya quarantine row
According to the US Department of Health and Human Services (HHS), the investigational therapy, known as MBP‑134, will be offered to individuals at high risk of exposure.
More To Read
- World's first AI‑designed vaccine tested in humans, breakthrough for pandemic preparedness
- Lake Victoria fishermen warn of Ebola screening gaps despite regional surveillance
- Burial teams attacked as Ebola patients flee treatment centres in eastern DRC
- DR Congo's Ebola cases hit 363, as Uganda reports 4 recoveries
- EAC ministers agree to harmonise border surveillance to contain Ebola outbreak
- Health teams undergo training to strengthen Ebola preparedness
Latest Stories
- How Kaptagat initiative is creating jobs, incomes through conservation efforts
- World's first AI‑designed vaccine tested in humans, breakthrough for pandemic preparedness
- MSF warns of rising civilian toll from drone strikes at Chad-Sudan border
- EPRA halts public hearings on electricity tariffs after Kenya Power withdraws review
Other Topics To Read
Top Stories Today
Comments
Sign in with Google to comment, reply, and like comments.
Continue with Google